Immix Biopharma, Inc. IMMX Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from Immix Biopharma, Inc.’s reported figures.
Based on the most recent quarter.
The official record: Immix Biopharma, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Immix Biopharma, Inc.'s current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Immix Biopharma, Inc.'s current ratio?
- Immix Biopharma, Inc. (IMMX) reported current ratio of 8.8× in Q1 2026.
- How has Immix Biopharma, Inc.'s current ratio changed year-over-year?
- Immix Biopharma, Inc.'s current ratio increased by 385.6% year-over-year, from 1.8× to 8.8×.
- What is the long-term trend for Immix Biopharma, Inc.'s current ratio?
- Over 5 years (2020 to 2025), Immix Biopharma, Inc.'s current ratio has grown at a 150.8% compound annual growth rate (CAGR), from 0.1× to 10×.
- What does current ratio mean?
- Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.